[2P-0646] Evaluation of Glycosylated Paclitaxel Encapsulated into Liposomes Conjugated with Anti-CD44 Antibody to Target Ovarian Cancer

〇Apriliana Cahya Khayrani¹、Hafizah Mahmud¹、Aung Ko Ko Oo¹、Tomonari Kasai^1,7、Maram Hussein Zaky Zahra^1,2、Tsukasa Shigehiro^1,8、Juan Du¹、Koji Hara³、Hiroki Hamada⁴、Yuhki Seno⁵、Tadakatsu Mandai⁶、Said M Afify¹、Masaharu Seno^1,2 (1.Graduate School of Natural Science and Tech, Okayama Univ、2.Graduate School of Interdisciplinary Science and Engineering in Health Systems (ISEHS), Okayama Univ、3.Ensuiko Sugar Refining Co., Ltd.、4.Faculty of Science, Okayama Univ of Science、5.Graduate School of Pharmaceutical Sciences, Tokushima Univ、6.Faculty of Life Science, Kurashiki Univ of Science and the Arts、7.School of Bioscience and Biotechnology, Tokyo Univ of Tech、8.Japan Society for the Promotion of Science)

Drug Delivery System, Ovarian cancer, CD44